Insulet Corporation (PODD)
USD 256.8
(-4.58%)
USD 256.8
(-4.58%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 939.9 Million USD | 22.38% |
| 2022 | 768 Million USD | 22.66% |
| 2021 | 626.1 Million USD | 17.95% |
| 2020 | 530.8 Million USD | 23.36% |
| 2019 | 430.3 Million USD | 25.55% |
| 2018 | 342.74 Million USD | 20.45% |
| 2017 | 284.55 Million USD | 28.3% |
| 2016 | 221.79 Million USD | 21.86% |
| 2015 | 182 Million USD | 16.98% |
| 2014 | 155.58 Million USD | 9.93% |
| 2013 | 141.53 Million USD | 10.31% |
| 2012 | 128.3 Million USD | 17.52% |
| 2011 | 109.17 Million USD | 40.1% |
| 2010 | 77.92 Million USD | 0.35% |
| 2009 | 77.65 Million USD | -8.38% |
| 2008 | 84.75 Million USD | 104.33% |
| 2007 | 41.48 Million USD | 83.16% |
| 2006 | 22.64 Million USD | 13.1% |
| 2005 | 20.02 Million USD | 41.49% |
| 2004 | 14.15 Million USD | 17.8% |
| 2003 | 12.01 Million USD | -5.19% |
| 2002 | 12.67 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 253 Million USD | -0.71% |
| 2024 Q2 | 279.6 Million USD | 10.51% |
| 2023 FY | 939.9 Million USD | 22.38% |
| 2023 Q4 | 254.8 Million USD | 6.83% |
| 2023 Q3 | 238.5 Million USD | 2.01% |
| 2023 Q1 | 212.8 Million USD | 9.8% |
| 2023 Q2 | 233.8 Million USD | 9.87% |
| 2022 Q1 | 171.8 Million USD | 5.08% |
| 2022 Q2 | 217 Million USD | 26.31% |
| 2022 Q3 | 185.4 Million USD | -14.56% |
| 2022 Q4 | 193.8 Million USD | 4.53% |
| 2022 FY | 768 Million USD | 22.66% |
| 2021 Q2 | 156.4 Million USD | 3.44% |
| 2021 FY | 626.1 Million USD | 17.95% |
| 2021 Q4 | 163.5 Million USD | 5.48% |
| 2021 Q1 | 151.2 Million USD | -10.21% |
| 2021 Q3 | 155 Million USD | -0.9% |
| 2020 Q3 | 128 Million USD | 11.3% |
| 2020 Q2 | 115 Million USD | -3.69% |
| 2020 Q1 | 119.4 Million USD | 3.02% |
| 2020 FY | 530.8 Million USD | 23.36% |
| 2020 Q4 | 168.4 Million USD | 31.56% |
| 2019 FY | 430.3 Million USD | 25.55% |
| 2019 Q1 | 99.43 Million USD | 5.69% |
| 2019 Q2 | 108.81 Million USD | 9.44% |
| 2019 Q3 | 106.07 Million USD | -2.52% |
| 2019 Q4 | 115.9 Million USD | 9.26% |
| 2018 Q1 | 75.81 Million USD | -5.56% |
| 2018 Q2 | 77.74 Million USD | 2.55% |
| 2018 Q3 | 95.1 Million USD | 22.32% |
| 2018 FY | 342.74 Million USD | 20.45% |
| 2018 Q4 | 94.07 Million USD | -1.08% |
| 2017 Q1 | 64.7 Million USD | -0.56% |
| 2017 FY | 284.55 Million USD | 28.3% |
| 2017 Q4 | 80.27 Million USD | 12.15% |
| 2017 Q3 | 71.57 Million USD | 5.26% |
| 2017 Q2 | 67.99 Million USD | 5.09% |
| 2016 Q2 | 51.74 Million USD | -0.01% |
| 2016 Q1 | 51.75 Million USD | -25.39% |
| 2016 Q4 | 65.07 Million USD | 22.26% |
| 2016 FY | 221.79 Million USD | 21.86% |
| 2016 Q3 | 53.22 Million USD | 2.86% |
| 2015 Q3 | 51.38 Million USD | 9.95% |
| 2015 Q1 | 41.43 Million USD | 6.45% |
| 2015 FY | 182 Million USD | 16.98% |
| 2015 Q4 | 69.36 Million USD | 34.98% |
| 2015 Q2 | 46.73 Million USD | 12.79% |
| 2014 FY | 155.58 Million USD | 9.93% |
| 2014 Q4 | 38.92 Million USD | -4.86% |
| 2014 Q1 | 34.69 Million USD | 5.74% |
| 2014 Q2 | 41.04 Million USD | 18.31% |
| 2014 Q3 | 40.91 Million USD | -0.31% |
| 2013 Q2 | 32.65 Million USD | 4.13% |
| 2013 FY | 141.53 Million USD | 10.31% |
| 2013 Q4 | 32.81 Million USD | -26.61% |
| 2013 Q3 | 44.7 Million USD | 36.91% |
| 2013 Q1 | 31.36 Million USD | -0.14% |
| 2012 Q4 | 31.4 Million USD | -4.43% |
| 2012 Q1 | 31.19 Million USD | 1.96% |
| 2012 Q3 | 32.86 Million USD | 0.03% |
| 2012 Q2 | 32.85 Million USD | 5.32% |
| 2012 FY | 128.3 Million USD | 17.52% |
| 2011 Q2 | 29.45 Million USD | 41.56% |
| 2011 Q4 | 30.59 Million USD | 7.99% |
| 2011 Q3 | 28.32 Million USD | -3.82% |
| 2011 Q1 | 20.8 Million USD | 8.82% |
| 2011 FY | 109.17 Million USD | 40.1% |
| 2010 Q1 | 19.11 Million USD | -0.94% |
| 2010 Q3 | 19.9 Million USD | 0.61% |
| 2010 Q2 | 19.78 Million USD | 3.51% |
| 2010 Q4 | 19.12 Million USD | -3.95% |
| 2010 FY | 77.92 Million USD | 0.35% |
| 2009 Q4 | 19.29 Million USD | 0.09% |
| 2009 FY | 77.65 Million USD | -8.38% |
| 2009 Q3 | 19.27 Million USD | -1.71% |
| 2009 Q2 | 19.61 Million USD | 0.76% |
| 2009 Q1 | 19.46 Million USD | -31.82% |
| 2008 Q4 | 28.55 Million USD | 44.6% |
| 2008 FY | 84.75 Million USD | 104.33% |
| 2008 Q1 | 16.68 Million USD | 21.47% |
| 2008 Q2 | 19.77 Million USD | 18.5% |
| 2008 Q3 | 19.74 Million USD | -0.12% |
| 2007 Q1 | 8.23 Million USD | 19.39% |
| 2007 Q4 | 13.73 Million USD | 27.3% |
| 2007 FY | 41.48 Million USD | 83.16% |
| 2007 Q3 | 10.79 Million USD | 23.71% |
| 2007 Q2 | 8.72 Million USD | 5.93% |
| 2006 FY | 22.64 Million USD | 13.1% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 100.0% |
| 2006 Q3 | 5.25 Million USD | 0.0% |
| 2006 Q4 | 6.89 Million USD | 31.37% |
| 2005 Q3 | -5.04 Million USD | 0.0% |
| 2005 Q1 | -5.04 Million USD | 0.0% |
| 2005 Q2 | -5.04 Million USD | 0.0% |
| 2005 FY | 20.02 Million USD | 41.49% |
| 2005 Q4 | -6.51 Million USD | -29.22% |
| 2004 FY | 14.15 Million USD | 17.8% |
| 2003 FY | 12.01 Million USD | -5.19% |
| 2002 FY | 12.67 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -8274.02% |
| Cerus Corporation | 143.15 Million USD | -556.561% |
| OrthoPediatrics Corp. | 137.01 Million USD | -585.963% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -8173.137% |
| Talis Biomedical Corporation | 67.18 Million USD | -1298.952% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -3667.738% |
| Inogen, Inc. | 236.08 Million USD | -298.119% |
| Spectral AI, Inc. | 20.86 Million USD | -4404.889% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -1578.483% |
| CVRx, Inc. | 76.14 Million USD | -1134.404% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -26541.187% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -7425.823% |
| Orthofix Medical Inc. | 667.42 Million USD | -40.824% |
| Venus Concept Inc. | 80.47 Million USD | -1067.926% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -1561.246% |
| Bioventus Inc. | 409.91 Million USD | -129.29% |
| BrainsWay Ltd. | 28.01 Million USD | -3254.629% |
| Envoy Medical, Inc. | 17.89 Million USD | -5151.425% |
| electroCore, Inc. | 32.03 Million USD | -2834.345% |
| IceCure Medical Ltd | 16.87 Million USD | -5469.448% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -2115.074% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -5230.338% |
| MaxCyte, Inc. | 84.84 Million USD | -1007.785% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -7472.653% |
| Nexalin Technology, Inc. | 5.78 Million USD | -16157.432% |
| PAVmed Inc | 64.82 Million USD | -1349.859% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -1740.127% |
| RxSight, Inc. | 103.85 Million USD | -805.055% |
| Sight Sciences, Inc. | 126.44 Million USD | -643.304% |
| SI-BONE, Inc. | 156.35 Million USD | -501.147% |
| TELA Bio, Inc. | 84.18 Million USD | -1016.443% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -1241.641% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -362.174% |
| LivaNova PLC | 843.54 Million USD | -11.422% |
| 908 Devices Inc. | 68.08 Million USD | -1280.582% |
| Alphatec Holdings, Inc. | 483.59 Million USD | -94.356% |
| Nemaura Medical Inc. | 7.13 Million USD | -13066.073% |
| NeuroPace, Inc. | 75.29 Million USD | -1148.273% |
| LENSAR, Inc. | 33.33 Million USD | -2719.474% |
| Apyx Medical Corporation | 51.01 Million USD | -1742.291% |
| Cutera, Inc. | 197.72 Million USD | -375.36% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -3692.825% |
| BioSig Technologies, Inc. | 28.53 Million USD | -3194.427% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -390.873% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -2506.489% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | -12.376% |
| Axonics, Inc. | 270.2 Million USD | -247.851% |
| Outset Medical, Inc. | 198.77 Million USD | -372.858% |
| IRIDEX Corporation | 31.81 Million USD | -2854.36% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -421.532% |
| IRadimed Corporation | 30.12 Million USD | -3020.227% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -10916.174% |
| INVO Bioscience, Inc. | 7.85 Million USD | -11868.228% |
| Telesis Bio, Inc. | 63.48 Million USD | -1380.414% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -854.669% |
| Varex Imaging Corporation | 224.8 Million USD | -318.105% |
| Quipt Home Medical Corp. | 148.66 Million USD | -532.218% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -7917.572% |
| Pulmonx Corporation | 112.68 Million USD | -734.08% |
| Dynatronics Corporation | 9.9 Million USD | -9386.249% |
| Modular Medical, Inc. | 17.52 Million USD | -5261.972% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -4555.967% |
| Semler Scientific, Inc. | 38.94 Million USD | -2313.465% |
| InMode Ltd. | 215.68 Million USD | -335.784% |
| Bruker Corporation | 1.07 Billion USD | 12.681% |
| Cytosorbents Corporation | 48.33 Million USD | -1844.479% |
| DexCom, Inc. | 1.69 Billion USD | 44.424% |
| Align Technology, Inc. | 2.07 Billion USD | 54.743% |
| Viveve Medical, Inc. | 22.17 Million USD | -4138.939% |
| ZimVie Inc. | 275.12 Million USD | -241.625% |
| Movano Inc. | 29.69 Million USD | -3065.712% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -584.704% |
| Nexalin Technology, Inc. | 5.78 Million USD | -16157.432% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -26541.187% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | -56.41% |
| Profound Medical Corp. | 33.6 Million USD | -2697.06% |
| enVVeno Medical Corporation | 25.23 Million USD | -3624.146% |
| Surmodics, Inc. | 98.69 Million USD | -852.309% |
| iCAD, Inc. | 22.22 Million USD | -4129.021% |
| Nuwellis, Inc. | 22.61 Million USD | -4056.459% |
| Biotricity, Inc. | 17.18 Million USD | -5369.448% |
| iRhythm Technologies, Inc. | 445.88 Million USD | -110.792% |
| Aethlon Medical, Inc. | 12.27 Million USD | -7555.46% |
| InspireMD, Inc. | 22.95 Million USD | -3995.425% |
| PAVmed Inc. | 64.82 Million USD | -1349.859% |
| BIOLASE, Inc. | 34.66 Million USD | -2611.693% |
| Beyond Air, Inc. | 61.7 Million USD | -1423.339% |
| FONAR Corporation | 28.6 Million USD | -3185.826% |
| AxoGen, Inc. | 149.33 Million USD | -529.386% |
| Vivani Medical, Inc. | 26.96 Million USD | -3385.63% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -430.741% |
| Inari Medical, Inc. | 448.59 Million USD | -109.52% |
| UFP Technologies, Inc. | 58.08 Million USD | -1518.034% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -18974.198% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -14775.863% |
| Tenon Medical, Inc. | 16.96 Million USD | -5439.25% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -12613.378% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -2031.155% |
| AdaptHealth Corp. | 1.07 Billion USD | 12.808% |
| Sintx Technologies, Inc. | 15.2 Million USD | -6083.146% |
| NanoVibronix, Inc. | 4.97 Million USD | -18800.06% |
| Quanterix Corporation | 118.1 Million USD | -695.851% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -7917.572% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -6408.101% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -139.364% |
| TransMedics Group, Inc. | 182.82 Million USD | -414.112% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -3249.011% |
| NeuroMetrix, Inc. | 11.09 Million USD | -8368.381% |
| Hyperfine, Inc. | 52.87 Million USD | -1677.69% |
| Establishment Labs Holdings Inc. | 172 Million USD | -446.444% |
| Biomerica, Inc. | 6.97 Million USD | -13369.475% |
| Bone Biologics Corporation | 9.42 Million USD | -9868.92% |
| AVITA Medical, Inc. | 80.77 Million USD | -1063.542% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -9015.317% |
| Silk Road Medical, Inc | 186.35 Million USD | -404.355% |